Institute of Transformation Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen University School of Medicine, 518300, Shenzhen, China.
The Key Laboratory of Stem Cell Biology, Institute of Health Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of Chinese Academy of Science, 200031, Shanghai, China.
Cell Death Dis. 2018 Nov 15;9(12):1140. doi: 10.1038/s41419-018-1189-2.
Tumor necrosis factor (TNF) and Toll-like receptor (TLR)3/TLR4 activation trigger necroptotic cell death through downstream signaling complex containing receptor-interacting protein kinase 1 (RIPK1), RIPK3, and pseudokinase mixed lineage kinase-domain-like (MLKL). However, the regulation of necroptotic signaling pathway is far less investigated. Here we showed that c-Jun N-terminal kinases (JNK1 and JNK2) displayed kinase-dependent and -independent functions in regulating TNF- and TLRs-mediated necroptosis. We found that RIPK1 and RIPK3 promoted cell-death-independent JNK activation in macrophages, which contributed to pro-inflammatory cytokines production. Meanwhile, blocking the kinase activity of JNK dramatically reduced TNF and TLRs-induced necroptotic cell death. Consistently, inhibition of JNK activity protected mice from TNF-induced death and Staphylococcus aureus-mediated lung damage. However, depletion of JNK protein using siRNA sensitized macrophages to necroptosis that was triggered by LPS or poly I:C but still inhibited TNF-induced necroptosis. Mechanistic studies revealed that RIPK1 recruited JNK to the necrosome complex and their kinase activity was required for necrosome formation and the phosphorylation of MLKL in TNF- and TLRs-induced necroptosis. Loss of JNK protein consistently suppressed the phosphorylation of MLKL and necrosome formation in TNF-triggered necroptosis, but differentially promoted the phosphorylation of MLKL and necrosome formation in poly I:C-triggered necroptosis by promoting the oligomeration of TRIF. In conclusion, our findings define a differential role for JNK in regulating TNF- and TLRs-mediated necroptosis by their kinase or scaffolding activities.
肿瘤坏死因子(TNF)和 Toll 样受体(TLR)3/TLR4 的激活通过下游信号复合物触发坏死性细胞死亡,该复合物包含受体相互作用蛋白激酶 1(RIPK1)、RIPK3 和假激酶混合谱系激酶结构域样(MLKL)。然而,坏死性信号通路的调节远未被深入研究。在这里,我们表明 c-Jun N 端激酶(JNK1 和 JNK2)在调节 TNF 和 TLR 介导的坏死性细胞死亡中表现出激酶依赖性和非依赖性功能。我们发现 RIPK1 和 RIPK3 在巨噬细胞中促进了细胞死亡非依赖性的 JNK 激活,这有助于促炎细胞因子的产生。同时,阻断 JNK 的激酶活性可显著减少 TNF 和 TLR 诱导的坏死性细胞死亡。一致地,抑制 JNK 活性可保护小鼠免受 TNF 诱导的死亡和金黄色葡萄球菌介导的肺损伤。然而,使用 siRNA 耗尽 JNK 蛋白会使巨噬细胞对 LPS 或聚 I:C 触发的坏死性细胞死亡敏感,但仍能抑制 TNF 诱导的坏死性细胞死亡。机制研究表明,RIPK1 将 JNK 募集到坏死小体复合物中,其激酶活性对于 TNF 和 TLR 诱导的坏死性细胞死亡中坏死小体的形成和 MLKL 的磷酸化是必需的。JNK 蛋白的缺失一致抑制了 TNF 触发的坏死性细胞死亡中 MLKL 的磷酸化和坏死小体的形成,但通过促进 TRIF 的寡聚化,促进了 poly I:C 触发的坏死性细胞死亡中 MLKL 的磷酸化和坏死小体的形成。总之,我们的研究结果定义了 JNK 通过其激酶或支架活性在调节 TNF 和 TLR 介导的坏死性细胞死亡中的差异作用。